5.9 B-Cell Breakaway Part 2

In this episode we are joined by some amazing collaborators from the EMEUNET to talk about the STRAP trials. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program STRAP trial, by the Emerging EULAR Network (EMEUNET) Links to theMednet.org Q&As about this region: In the treatment of lupus nephritis, which patients may benefit from the use of rituximab or other B-cell depleting agents during induction? What are the potential barriers to the widespread use of obinutuzumab in proliferative lupus nephritis? How do you envision incorporating CAR-T therapy into your clinical practice? Does synovial biopsy provide diagnostic value in undifferentiated inflammatory arthritis? To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/